^
Association details:
Biomarker:No biomarker
Cancer:Waldenstrom Macroglobulinemia
Regimen:R-CHOP (cyclophosphamide + doxorubicin hydrochloride + + Rituxan (rituximab) + vincristine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: THERAPY FOR PREVIOUSLY TREATED WM/LPL...Useful in Certain Circumstances...Cyclophosphamide/doxorubicin/vincristine/prednisone/rituximab